Search the Newsreel

Everus Construction Group (NYSE:ECG) Issues Quarterly Earnings Results, Beats Estimates By $0.50 EPS

Veru - Interim Analysis Results Expected Q1 2

The article indicates that Veru is expecting to release interim analysis results in the first quarter of the second year (Q1 2). No further details about the nature of these results or the specific year are provided in the snippet.

Earnings Flash (ECG) Everus Construction Group, Inc. Reports Q2 Revenue $1.23B, vs. FactSet Est of $1.08B

Everus Construction Group, Inc. (ECG) reported strong Q2 results, with revenue reaching $1.23 billion, significantly exceeding FactSet's estimate of $1.08 billion. Following these positive results, the company also raised its 2026 revenue outlook to a range of $4.5 billion to $4.7 billion, surpassing the …

Everus Reports Second Quarter 2026 Results, Raises 2026 Guidance

BISMARCK, N.D., August 04, 2026--(BUSINESS WIRE)--Everus Construction Group (NYSE: ECG) today reported financial results for second quarter 2026. Second Quarter 2026 Summary (All comparisons versus the prior-year period unless otherwise noted, and results denoted with * are quarterly records.) Revenues of $1.23 billion*, up …

Everus To Acquire Epsilon Industries For $295 Million

Everus Construction Group is set to acquire Epsilon Industries for $295 million in cash, with the deal expected to close in Q3 2026. Epsilon, a designer and manufacturer of modular infrastructure systems, is projected to generate $250 million in revenue in 2026. This acquisition …

Everus Construction earnings on deck as data center boom tests margins

Everus Construction Group Inc. is set to report second-quarter earnings, with analysts anticipating a significant sequential decline in EPS, which tests investor confidence in the company's data center construction exposure. The company's record backlog and recent acquisition of Epsilon Industries are key factors investors …

Veru receives patent allowance for enobosarm combination therapy

Veru Inc. announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent application covering compositions combining selective androgen receptor modulator compounds with weight loss drugs, specifically enobosarm with semaglutide. This patent aims to preserve lean body mass, …

Class Action Lawsuit Filed Against Everus Construction Group, Inc

A class action securities lawsuit has been filed against Everus Construction Group, Inc. (NYSE: ECG) by Levi & Korsinsky, LLP, seeking to recover losses for shareholders who purchased shares between October 31, 2024, and February 11, 2025. The lawsuit alleges that the company made …

Veru Announces Notice of Allowance for Key Methods of Use

Veru Inc. announced that the USPTO has issued a Notice of Allowance for a U.S. Patent Application concerning the use of enobosarm in combination with weight loss drugs like semaglutide for quality weight loss, with patent protection until at least October 2044. The patent …

Veru Inc. Announces August 10, 2026 Conference Call to Discuss Fiscal Third Quarter Results and Business Update

Veru Inc. will host a conference call and audio webcast on August 10, 2026, to discuss its fiscal third quarter 2026 financial results and provide a business update. The company is advancing its Phase 2b PLATEAU study, which investigates enobosarm in combination with a …

Veru's obesity study expects interim data in 2027

Veru Inc. announced it will host a conference call on August 10, 2026, to discuss its fiscal 2026 third-quarter financial results and provide a business update, specifically highlighting its obesity program. The company's fully enrolled Phase 2b PLATEAU trial of enobosarm with semaglutide is …

Everus Construction Group (ECG) Stock May Be Below Fair Value Following Its 79% Run

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Everus Construction Group stock has surged over the past year, yet the Discounted Cash …

Price to book forward of Veru Inc. – NASDAQ:VERU

This article provides the "Price to book forward" financial metric for Veru Inc. (NASDAQ: VERU). It is presented on a financial data platform, likely TradingView, which offers various market tools and data for investors. The content is primarily a financial data point without further …

Everus agrees to buy Epsilon, with 50 engineers and 120 skilled trades workers

Everus Construction Group announced its definitive agreement to acquire Epsilon Industries for $295 million in cash. Epsilon, known for its modular mechanical and electrical infrastructure systems, will enhance Everus's off-site construction offerings, expand its geographic reach, and diversify its market exposure into sectors like …

Everus Construction stock rises on $295M Epsilon deal

Everus Construction Group (NYSE:ECG) saw its shares climb 3.9% after announcing a definitive agreement to acquire Epsilon Industries for $295 million in cash. Epsilon, a designer and manufacturer of modular construction systems, is expected to generate $250 million in revenue for 2026. This acquisition …

Everus Construction to acquire Epsilon Industries for $295 million

Everus Construction Group announced its definitive agreement to acquire Epsilon Industries for $295 million in cash. Epsilon Industries specializes in modular mechanical and electrical building infrastructure systems, providing off-site construction solutions across North America. This acquisition aims to expand Everus's capabilities in modular construction …

Everus Construction to Acquire Modular Infrastructure Firm Epsilon

Everus Construction Group (ECG) is set to acquire Epsilon Industries for $295 million, a move that will expand Everus' modular prefabrication capabilities and market reach in North America. The acquisition, expected to close in Q3 2026, aims to strengthen Everus' position in high-growth sectors …

Everus to Acquire Epsilon Industries for $295M Cash, Expands Modular Off‑Site Capabilities

Everus Construction Group announced its definitive agreement to acquire Epsilon Industries for $295 million in cash, aiming to expand its off-site modular construction capabilities. The acquisition is expected to close in Q3 2026, be cash accretive, and broaden Everus's geographic reach and market exposure. …

Everus to Acquire Epsilon Industries, Premier Off-Site Modular Construction Solutions Provider

Strengthens Off-Site Modular Construction Offerings Enhances Geographic and Market Exposure Attractive Growth Profile BISMARCK, N.D., July 31, 2026--(BUSINESS WIRE)--Everus Construction Group (NYSE: ECG) announced today that it has entered into a definitive agreement to acquire Epsilon Industries, a premier designer and manufacturer of complex, …

Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference

Veru Inc. announced that its Chairman, President, and CEO, Mitchell Steiner, M.D., will participate in a fireside chat at the Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026. The company is a late clinical-stage biopharmaceutical firm focusing on cardiometabolic and inflammatory diseases, …

Veru Inc (VERU) Risk Assessment: Volatility, Financial Risk & Investment Risk

This report provides a risk assessment for Veru Inc (VERU), noting its current score of 2.26, ranking it 227th out of 385 in the Biotechnology & Medical Research industry. Key metrics include a negative beta value, indicating underperformance in rising markets and smaller declines …

Veru Inc Today's Market Trends | VERU Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey

Veru Inc (VERU) is a late clinical-stage biopharmaceutical company focused on developing treatments for metabolic diseases, oncology, and ARDS. Despite a recent decline in stock performance, analysts rate VERU as a Strong Buy with a target price of $24.50, suggesting significant upside potential. The …

Veru Inc (VERU) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes Veru Inc.'s (VERU) financial health, noting its current financial score of 4.98, which ranks 378 out of 385 in the Biotechnology & Medical Research industry. Despite this robust financial status, the company's operating efficiency is low. Key financial metrics such as …

Everus Construction Group (ECG) Projected to Release Quarterly Earnings on Tuesday

VERU|Veru Inc|Price:2.220|Chg%:-0.060

This article provides a comprehensive stock analysis of Veru Inc. (VERU) by TradingKey, detailing its financial health, valuation, earnings forecast, price momentum, institutional confidence, and risk assessment. The company's fundamentals are considered healthy with significant growth potential, although its market performance has been weak …

Veru Inc (VERU) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Veru Inc (VERU), noting its current valuation score of 8.26, ranking it 155 out of 386 in the Biotechnology & Medical Research industry. It highlights the company's P/E ratio of -2.95, which is significantly below its recent …

Veru Inc (VERU) Cash Flow

This article provides a detailed historical cash flow statement for Veru Inc (VERU), including operating, investing, and financing cash flows, presented both quarterly and annually. It also offers definitions and explanations of these financial terms and answers frequently asked questions regarding Veru Inc's cash …

Everus Construction Group (ECG) Strengthens from Long-Term Infrastructure Demand

Wasatch Global Investors, an asset management company, released its "Small Cap Growth Strategy" Q2 2026 investor letter. A copy of the letter can be downloaded here. Small-cap equities experienced strong gains in the second quarter, primarily driven by companies associated with artificial intelligence (AI). …

VERU Completes Enrollment in Phase 2b PLATEAU Study

Veru Inc. (VERU) has completed participant enrollment for its Phase 2b PLATEAU clinical trial, which will evaluate the effects of oral enobosarm in older obese individuals starting semaglutide therapy. The company has a low GF Score™ of 28/100 and negative earnings, but shows strong …

Veru Inc. Revenue Breakdown – NASDAQ:VERU

Veru Market Sentiment

This article provides an overview of various market sentiment signals for Veru (VERU), including analyst consensus, short interest, options flow, and insider activity. It highlights a "Buy" analyst consensus with an average price target significantly above the current stock price, but also notes a …

TradingKey

This article provides a detailed quarterly and annual income statement for Veru Inc (VERU), showing key financial metrics like total revenue, cost of revenue, operating expenses, and net income over a long historical period. It also includes frequently asked questions about how to interpret …

Veru Inc (VERU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Veru Inc (VERU), segmenting its revenue by business and by region. It highlights that the company's revenue primarily comes from its FC2 product, totaling $16.89 million, with ENTADFI showing no revenue. Geographically, the United States accounts …

Lost Money on Everus Construction Group, Inc. (ECG)? Contact Levi & Korsinsky Before June 3, 2025 to Join Class Action

Levi & Korsinsky LLP has filed a class action securities lawsuit against Everus Construction Group, Inc. (NYSE: ECG) to recover losses for shareholders who were negatively impacted by alleged securities fraud between October 31, 2024, and February 11, 2025. The lawsuit claims that Everus …

ECG|Everus Construction Group Inc|Price:129.990|Chg%:-7.935

This article provides a detailed financial overview of Everus Construction Group Inc (ECG), including its current stock price, market capitalization, and P/E ratio. It presents various financial statements such as income statement, balance sheet, and cash flow statement on both quarterly and annual bases, …

Veru Inc (VERU) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Veru Inc (VERU), detailing its current price momentum score, ranking within the Biotechnology & Medical Research industry, and its trading range between support and resistance levels. It also presents an overview of various technical indicators like MACD, …